Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

News Daily News

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

December 26, 2025

Top Endovascular News of 2023

News Daily News

Top Endovascular News of 2023

December 28, 2023

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

News Daily News

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

August 05, 2022

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

News Daily News

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

September 17, 2020

FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One

News Daily News

FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One

June 19, 2019

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

News Daily News

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

March 01, 2019

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

News Daily News

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

February 13, 2019

News Daily News

Drug-Coated Balloons Beat Angioplasty for SFA In-Stent Restenosis, but Long-Term Solutions Needed

July 07, 2016

News Daily News

Paradoja Campeau: ¿Sacrifica el Abordaje Radial la Competencia Femoral?

November 24, 2015

News Daily News

Campeau Paradox: Is Femoral Proficiency Lost When Radial Access Thrives?

November 24, 2015

News Daily News

Study Compares Bypass, Angioplasty for SFA Disease

March 07, 2012

News Daily News

Estudio compara Bypass y Angioplastia contra la Enfermedad de la AFS

March 07, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.